Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:1
  • preuzimanja u poslednjih 30 dana:0
članak: 1 od 1  
Back povratak na rezultate
Vojnosanitetski pregled
2014, vol. 71, br. 9, str. 870-874
jezik rada: engleski
vrsta rada: aktuelni problemi
objavljeno: 14/09/2014
doi: 10.2298/VSP130317037T
Da li ima dovoljno dokaza za rutinsko korišćenje stentova obloženih lekom u akutnom infarktu miokarda sa ST elevacijom?
Klinički centar Srbije, Klinika za kardiologiju, Beograd

e-adresa: misa.tesic@gmail.com

Sažetak

Članak ne sadrži sažetak.

Ključne reči

Reference

Bangalore, S., Kumar, S., Fusaro, M., Amoroso, N., Attubato, M.J., Feit, F., Bhatt, D.L., Slater, J. (2012) Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation, 125(23): 2873-91
Brar, S.S., Leon, M.B., Stone, G.W., Mehran, R., Moses, J.W., Brar, S.K., Dangas, G. (2009) Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol, 53(18): 1677-89
Camenzind, E., Wijns, W., Mauri, L., i dr. (2012) Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. Lancet, 380: 139
Camenzind, E., Steg, P.G., Wijns, W. (2007) A Cause for Concern. Circulation, 115(11): 1440-1455
Grines, C.L., Cox, D.A., Stone, G.W., Garcia, E., Mattos, L.A., Giambartolomei, A., Brodie, B.R., Madonna, O., Eijgelshoven, M., Lansky, A.J., Neill, O.W.W., Morice, M.C. (1999) Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med, 341(26): 1949-56
Guagliumi, G., Costa, M.A., Sirbu, V., Musumeci, G., Bezerra, H.G., Suzuki, N., Matiashvili, A., Lortkipanidze, N., Mihalcsik, L., Trivisonno, A., Valsecchi, O., Mintz, G.S. (2011) Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardi. Circulation, 123(3): 274-81
Guo, N., Maehara, A., Mintz, G.S., i dr. (2010) Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularizat. Circulation, 122: 107
Iakovou, I., Schmidt, T., Bonizzoni, E., Ge, L., Sangiorgi, G.M., Stankovic, G., Airoldi, F., Chieffo, A., Montorfano, M., Carlino, M., Michev, I., Corvaja, N., Briguori, C., Gerckens, U. (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA, 293(17): 2126-30
Joner, M., Finn, A.V., Farb, A., Mont, E.K., Kolodgie, F.D., Ladich, E., Kutys, R., Skorija, K., Gold, H.K., Virmani, R. (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol, 48(1): 193-202
Kalesan, B., Pilgrim, T., Heinimann, K., i dr. (2012) Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction. Eur Heart J, 33: 977
Kaltoft, A., Kelbaek, H., Thuesen, L., Lassen, J.F., Clemmensen, P., Kløvgaard, L., Engstrøm, T., Bøtker, H.E., Saunamäki, K., Krusell, L.R., Jørgensen, E., Tilsted, H., Christiansen, E.H. (2010) Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) T. J Am Coll Cardiol, 56(8): 641-5
Kastrati, A., Dibra, A., Spaulding, C., Laarman, G.J., Menichelli, M., Valgimigli, M., di Lorenzo, E., Kaiser, C., Tierala, I., Mehilli, J., Seyfarth, M., Varenne, O., Dirksen, M.T., Percoco, G., Varricchio, A., Pittl, U., Syvanne, M., Suttorp, M.J. (2007) Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J, 28(22): 2706-2713
Keeley, E.C., Boura, J.A., Grines, C.L. (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet, 361(9351): 13-20
Kelbaek, H., Thuesen, L., Helqvist, S., Clemmensen, P., Kløvgaard, L., Kaltoft, A., Andersen, B., Thuesen, H., Engstrøm, T., Bøtker, H.E., Saunamäki, K., Krusell, L.R., Jørgensen, E. (2008) Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial. Circulation, 118(11): 1155-62
Koppara, T., Joner, M., Bayer, G., Steigerwald, K., Diener, T., Wittchow, E. (2012) Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation. Thromb Haemost, 107: 116
Laarman, G.J., Suttorp, M.J., Dirksen, M.T., Heerebeek, L., Kiemeneij, F., Slagboom, T., Wieken, R.L., Tijssen, J.G.P., Rensing, B.J., Patterson, M. (2006) Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med, 355(11): 1105-13
Morice, M., Serruys, P.W., Sousa, E.J., Fajadet, J., Ban, H.E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., Molnàr, F., Falotico, R. (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med, 346(23): 1773-80
Nakazawa, G., Finn, A.V., Joner, M., Ladich, E., Kutys, R., Mont, E.K., Gold, H.K., Burke, A.P., Kolodgie, F.D., Virmani, R. (2008) Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients: An Autopsy Study. Circulation, 118(11): 1138-1145
Ong, A.T.L., Hoye, A., Aoki, J., Mieghem, C.A.G., Rodriguez, G.G.A., Sonnenschein, K., Regar, E., McFadden, E.P., Sianos, G., Giessen, W.J., Jaegere, P.P.T., Feyter, P., Domburg, R.T. (2005) Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol, 45(6): 947-53
Palmerini, T., Kirtane, A.J., Serruys, P.W., i dr. (2012) Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials. Circ Cardiovasc Interv, 5: 357-3
Palmerini, T., Biondi-Zoccai, G., Riva, D.D., i dr. (2012) Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet, 379: 139
Piscione, F., Piccolo, R., Cassese, S., i dr. (2010) Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis of randomised trials and an adjusted indirect comparison. EuroIntervention, 5: 853-8
Raber, L., Kelbaek, H., Ostojic, M., i dr. (2012) Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. JAMA, 308: 777
Sabate, M., Cequier, A., Iniguez, A., i dr. (2012) Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet, 380: 148
Sarno, G., Lagerqvist, B., Frobert, O., i dr. (2012) Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J, 33: 606
Sianos, G., Papafaklis, M.I., Daemen, J., Vaina, S., Mieghem, C.A., Domburg, R.T., Michalis, L.K., Serruys, P.W. (2007) Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol, 50(7): 573-83
Spaulding, C., Henry, P., Teiger, E., Beatt, K., Bramucci, E., Carrié, D., Slama, M.S., Merkely, B., Erglis, A., Margheri, M., Varenne, O., Cebrian, A., Stoll, H., Snead, D.B., Bode, C. (2006) Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med, 355(11): 1093-104
Spaulding, C., Teiger, E., Commeau, P., Varenne, O., Bramucci, E., Slama, M., Beatt, K., Tirouvanziam, A., Polonski, L., Stella, P.R., Clugston, R., Fajadet, J., Boisgelin, X., Bode, C., Carrié, D. (2011) Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty). JACC Cardiovasc Interv, 4(1): 14-23
Stefanini, G.G., Kalesan, B., Serruys, P.W., i dr. (2011) Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet, 378: 194
Stefanini, G.G., Byrne, R.A., Serruys, P.W., Waha, A., Meier, B., Massberg, S., Jüni, P., Schömig, A., Windecker, S., Kastrati, A. (2012) Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized. Eur Heart J, 33(10): 1214-22
Stone, G.W., Rizvi, A., Sudhir, K., i dr. (2012) Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. J Am Coll Cardiol, 58: 19-2
Stone, G.W., Ellis, S.G., Cannon, L., Mann, T.J., Greenberg, J.D., Spriggs, D., Shaughnessy, C.O.D., de Maio, S., Hall, P., Popma, J.J., Koglin, J., Russell, M.E. (2005) Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA, 294(10): 1215-23
Stone, G.W., Grines, C.L., Cox, D.A., Garcia, E., Tcheng, J.E., Griffin, J.J., Guagliumi, G., Stuckey, T., Turco, M., Carroll, J.D., Rutherford, B.D., Lansky, A.J. (2002) Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med, 346(13): 957-66
Stone, G.W., Rizvi, A., Newman, W., Mastali, K., Wang, J.C., Caputo, R., Doostzadeh, J., Cao, S., Simonton, C.A., Sudhir, K., Lansky, A.J., Cutlip, D.E., Kereiakes, D.J. (2010) Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med, 362(18): 1663-74
Stone, G.W., Witzenbichler, B., Guagliumi, G., Peruga, J.Z., Brodie, B.R., Dudek, D., Kornowski, R., Hartmann, F., Gersh, B.J., Pocock, S.J., Dangas, G., Wong, C.S., Fahy, M., Parise, H., Mehran, R. (2011) Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet, 377(9784): 2193-204
Stone, G.W., Lansky, A.J., Pocock, S.J., Gersh, B.J., Dangas, G., Wong, C.S., Witzenbichler, B., Guagliumi, G., Peruga, J.Z., Brodie, B.R., Dudek, D., Möckel, M., Ochala, A., Kellock, A. (2009) Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med, 360(19): 1946-59
Sudhir, K., Hermiller, J.B., Naidu, S.S., i dr. (2012) Clinical outcomes in real-world patients with acute myocardial infarction receiving XIENCE V((R)) everolimus-eluting stents: One-year results from the XIENCE V USA study. Catheter Cardiovasc Interv, [Epub ahead of print]
Valgimigli, M., Percoco, G., Malagutti, P., Campo, G., Ferrari, F., Barbieri, D., Cicchitelli, G., McFadden, E.P., Merlini, F., Ansani, L., Guardigli, G., Bettini, A., Parrinello, G., Boersma, E. (2005) Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA, 293(17): 2109-17
Valgimigli, M., Campo, G., Percoco, G., Bolognese, L., Vassanelli, C., Colangelo, S., Cesare, N., Rodriguez, A.E., Ferrario, M., Moreno, R., Piva, T., Sheiban, I., Pasquetto, G., Prati, F. (2008) Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. JAMA, 299(15): 1788-99
Vink, M.A., Dirksen, M.T., Suttorp, M.J., Tijssen, J.G.P., Etten, J., Patterson, M.S., Slagboom, T., Kiemeneij, F., Laarman, G.J. (2011) 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional. JACC Cardiovasc Interv, 4(1): 24-9
Win, H.K., Caldera, A.E., Maresh, K., i dr. (2007) Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA, 297: 200